Immunotherapy: Open Access

Immunotherapy: Open Access
Open Access

ISSN: 2471-9552

Volume 3, Issue 1 (2017)

Editorial

Pages: 1 - 3

Multiscale Modeling of Inflammation and Inflammatory Diseases

Jie-Lou Liao*

DOI: 10.4172/2471-9552.1000e107

Share this article

Short Communication

Pages: 1 - 4

IL4I1: An Emerging Target to Reinvigorate Antitumor Immune Responses

Flavia Castellano* and Valérie Molinier-Frenkel

DOI: 10.4172/2471-9552.1000132

Share this article

Review Article

Pages: 1 - 5

The Excellent Antitumor Effect of IL-24 and the Complete Eradication of the Xenograft Tumor with CTGVT-DG Strategy

Xin-Yuan Liu*,Kang-Jian Zhang,Jin-Fa Gu, Xian-Long Fangi, Ai-min Ni,Sheng-Fei He and Qi Kang

DOI: 10.4172/2471-9552.1000133

Share this article

Research Article

Pages: 1 - 5

Aviscumine (ME-503)-Skin Reaction as significant Factor for its Efficacy Expanded Evaluation of the Results from the Phase II Trial NCT00658437 in Patients with Unresectable stage IV Metastatic Melanoma

Uwe Trefzer, Ralf Gutzmer, Tabea Wilhelm, Florian Schenck, Katharina C. Kähler, Volkmar Jacobi, Klaus Witthohn, Hans Lentzen* and Peter Mohr

DOI: 10.4172/2471-9552.1000135

Share this article

Review Article

Pages: 1 - 8

Overview of the Soluble and Membrane-bound Tumor Factors Limiting NK-mediated Immune Surveillance

Cristina Bottino, Mariella Della Chiesa, Alessandra Dondero*, Francesca Bellora, Beatrice Casu, Alessandro Moretta and Roberta Castriconi

DOI: 10.4172/2471-9552.1000136

Share this article
Top